{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:31:20Z","timestamp":1787020280303,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009594","name":"University of P\u00e9cs","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009594","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The cost-effectiveness of treatment strategies for patients with Major Depressive Disorder (MDD) who have not responded to two adequate treatments with antidepressants (TRD) are still unclear. The aim of this analysis was to evaluate the cost-effectiveness of add-on repetitive Transcranial Magnetic Stimulation (rTMS) compared with standard treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A Markov-model simulated clinical events over one year from the perspective of healthcare payer. Third- and fourth-line treatment pathways (augmentation, antidepressant switch or combination, and Electro-Convulsive Therapy (ECT)) were defined based on medical practice guidelines. Transition probabilities were derived from a recent meta-analysis and scientific publications. Resource utilization and cost estimates were based on the patient-level database of a large university hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Incremental Quality-Adjusted Life Years (QALYs) and costs were 0.053 and 785 \u20ac, respectively, corresponding to an Incremental Cost-Effectiveness Ratio (ICER) of 14,670 \u20ac per QALY. The difference in cost between standard treatment and rTMS is explained by the rTMS sessions used in acute (\u20ac660) and maintenance (\u20ac57\/month) treatments, partly offset by lower hospital costs due to higher remission rates in the rTMS arm. Key parameters driving the ICER were incremental utility of remission, unit cost of rTMS treatment and remission rate. At a threshold of \u20ac22,243 add-on rTMS is a cost-effective alternative to pharmacotherapy. Evidence on long-term effectiveness is not yet available, so results are estimated for a one-year period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Not only does rTMS treatment have beneficial clinical effects compared with drug therapy in TRD, but it also appears to offer good value-for-money, especially in centres with larger numbers of patients where unit costs can be kept low.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-022-04078-9","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T01:02:29Z","timestamp":1656378149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder"],"prefix":"10.1186","volume":"22","author":[{"given":"Antal","family":"Zempl\u00e9nyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"J\u00f3zwiak-Hagym\u00e1sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalma","family":"Erd\u0151si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Boncz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"T\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Osv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Voros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"4078_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","volume":"126","author":"Q Liu","year":"2020","unstructured":"Liu Q, He H, Yang J, Feng X, Zhao F, Lyu J. Changes in the global burden of depression from 1990 to 2017: findings from the global burden of disease study. J Psychiatr Res. 2020;126:134\u201340.","journal-title":"J Psychiatr Res"},{"key":"4078_CR2","first-page":"17","volume":"27","author":"Z Rihmer","year":"2017","unstructured":"Rihmer Z, Szili I, Kalabay L, Torzsa P. A depresszi\u00f3 \u00e9s \u00f6ngyilkoss\u00e1gi vesz\u00e9ly sz\u0171r\u00e9se a h\u00e1ziorvosi \u00e9s \u00e1ltal\u00e1nos orvosi gyakorlatban. LAM. 2017;27:17\u201324.","journal-title":"LAM."},{"issue":"11","key":"4078_CR3","doi-asserted-by":"publisher","first-page":"e1001547","DOI":"10.1371\/journal.pmed.1001547","volume":"10","author":"AJ Ferrari","year":"2013","unstructured":"Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJL, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547.","journal-title":"PLoS Med"},{"issue":"2","key":"4078_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.eurpsy.2011.08.002","volume":"27","author":"HJ M\u00f6ller","year":"2012","unstructured":"M\u00f6ller HJ, Bitter I, Bobes J, Fountoulakis K, H\u00f6schl C, Kasper S. Position statement of the European psychiatric association (EPA) on the value of antidepressants in the treatment of unipolar depression. European Psychiatry. 2012;27(2):114\u201328.","journal-title":"European Psychiatry"},{"issue":"1","key":"4078_CR5","doi-asserted-by":"publisher","first-page":"e0245510","DOI":"10.1371\/journal.pone.0245510","volume":"16","author":"P D\u00f6me","year":"2021","unstructured":"D\u00f6me P, Kunovszki P, Tak\u00e1cs P, Feh\u00e9r L, Bal\u00e1zs T, Dede K, et al. Clinical characteristics of treatment-resistant depression in adults in Hungary: real-world evidence from a 7-year-long retrospective data analysis. PLoS One. 2021;16(1):e0245510.","journal-title":"PLoS One"},{"issue":"02","key":"4078_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4088\/JCP.14m09298","volume":"76","author":"PE Greenberg","year":"2015","unstructured":"Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). The Journal of Clinical Psychiatry. 2015;76(02):155\u201362.","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1","key":"4078_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12888-019-2222-4","volume":"19","author":"DH Jaffe","year":"2019","unstructured":"Jaffe DH, Rive B, Denee TR. The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study. BMC Psychiatry. 2019;19(1):247.","journal-title":"BMC Psychiatry."},{"issue":"1","key":"4078_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatr. 2006;163(1):28\u201340.","journal-title":"Am J Psychiatr"},{"key":"4078_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.neubiorev.2017.08.019","volume":"84","author":"H Akil","year":"2018","unstructured":"Akil H, Gordon J, Hen R, Javitch J, Mayberg H, McEwen B, et al. Treatment resistant depression: a multi-scale, systems biology approach. Neurosci Biobehav Rev. 2018;84:272\u201388.","journal-title":"Neurosci Biobehav Rev"},{"key":"4078_CR10","unstructured":"European Medicines Agency. Guideline on clinical investigation of medicinal products in the treatment of depression [Internet]. Vol. EMA\/CHMP\/185423\/2010, European Medicines Agency. 2013 [cited 2021 Dec 6]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-investigation-medicinal-products-treatment-depression_en.pdf"},{"issue":"11","key":"4078_CR11","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.clinph.2014.05.021","volume":"125","author":"JP Lefaucheur","year":"2014","unstructured":"Lefaucheur JP, Andr\u00e9-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125(11):2150\u2013206.","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"4078_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/WNN.0000000000000031","volume":"27","author":"SE Nadeau","year":"2014","unstructured":"Nadeau SE, Bowers D, Jones TL, Wu SS, Triggs WJ, Heilman KM. Cognitive effects of treatment of depression with repetitive Transcranial magnetic stimulation. Cogn Behav Neurol. 2014;27(2):77\u201387.","journal-title":"Cogn Behav Neurol"},{"issue":"5","key":"4078_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/15622975.2013.804195","volume":"14","author":"M Bauer","year":"2013","unstructured":"Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, M\u00f6ller HJ. World Federation of Societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry. 2013;14(5):334\u201385.","journal-title":"World J Biol Psychiatry"},{"key":"4078_CR14","unstructured":"NICE. Repetitive transcranial magnetic stimulation for depression. NICE Guidance 2015 [cited 2021 Dec 6]. Available from: https:\/\/www.nice.org.uk\/guidance\/ipg542\/resources\/repetitive-transcranial-magnetic-stimulation-for-depression-pdf-1899871923433669"},{"issue":"9","key":"4078_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/0706743716660033","volume":"61","author":"R v Milev","year":"2016","unstructured":"Milev R v, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J, et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the Management of Adults with major depressive disorder. The. Can J Psychiatr. 2016;61(9):561\u201375.","journal-title":"Can J Psychiatr"},{"key":"4078_CR16","unstructured":"D\u00f6me P, Rihmer Z, Bitter I, Gonda X, Herold R, Kurimay T, et al. Major (unipolar) depressive disorder: diagnostic and therapeutic guidelines. Eg\u00e9szs\u00e9g\u00fcgyi K\u00f6zl\u00f6ny (In Hungarian). 2021;71:970\u20131031."},{"issue":"3","key":"4078_CR17","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.brs.2016.03.010","volume":"9","author":"T Perera","year":"2016","unstructured":"Perera T, George MS, Grammer G, Janicak PG, Pascual-Leone A, Wirecki TS. The clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimul. 2016;9(3):336\u201346.","journal-title":"Brain Stimul."},{"issue":"3","key":"4078_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s12325-009-0013-x","volume":"26","author":"KN Simpson","year":"2009","unstructured":"Simpson KN, Welch MJ, Kozel FA, Demitrack MA, Nahas Z. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis. Adv Ther. 2009;26(3):346\u201368.","journal-title":"Adv Ther"},{"issue":"5","key":"4078_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jval.2015.04.004","volume":"18","author":"KH Nguyen","year":"2015","unstructured":"Nguyen KH, Gordon LG. Cost-effectiveness of repetitive Transcranial magnetic stimulation versus antidepressant therapy for treatment-resistant depression. Value Health. 2015;18(5):597\u2013604.","journal-title":"Value Health"},{"key":"4078_CR20","unstructured":"Ludwig Boltzmann Institute for Health Technology Assessment; Basque Office for Health Technology Assessment. Repetitive Transcranial Magnetic Stimulation For Treatment-Resistant Major Depression [Internet]. 2017 [cited 2021 Dec 14]. Available from: https:\/\/www.eunethta.eu\/wp-content\/uploads\/2018\/01\/OTCA05_Repetitive-transcranial-magnetic-stimulation-for-TRD.pdf"},{"issue":"2","key":"4078_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.clinph.2019.11.002","volume":"131","author":"JP Lefaucheur","year":"2020","unstructured":"Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, di Lazzaro V, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014\u20132018). Clin Neurophysiol. 2020;131(2):474\u2013528.","journal-title":"Clin Neurophysiol"},{"issue":"5","key":"4078_CR22","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.brs.2019.06.016","volume":"12","author":"AM Fukuda","year":"2019","unstructured":"Fukuda AM, Tirrell E, Gobin AP, Carpenter LL. Repetitive Transcranial magnetic stimulation for depression relapse or recurrence: naturalistic retreatment series outcomes. Brain Stimul. 2019;12(5):1328\u20139.","journal-title":"Brain Stimul"},{"key":"4078_CR23","doi-asserted-by":"crossref","unstructured":"John Rush A, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: a STAR*D report. Am J Psychiatry. 2006;163 Available from: www.star-d.org.","DOI":"10.1176\/ajp.2006.163.11.1905"},{"key":"4078_CR24","doi-asserted-by":"crossref","unstructured":"Alves LPC, Freire TFV, Fleck MPA, Rocha NS. A naturalistic study of high-dose unilateral ECT among severely depressed inpatients: how does it work in the clinical practice? BMC Psychiatry. 2016;16:396.","DOI":"10.1186\/s12888-016-1095-z"},{"issue":"6","key":"4078_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1017\/S1092852913000357","volume":"18","author":"PG Janicak","year":"2013","unstructured":"Janicak PG, Dunner DL, Aaronson ST, Carpenter LL, Boyadjis TA, Brock DG, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice. CNS Spectrums. 2013;18(6):322\u201332.","journal-title":"CNS Spectrums"},{"key":"4078_CR26","unstructured":"The Central Bank of Hungary. Exchange rates [Internet]. 2020 [cited 2021 Dec 6]. Available from: https:\/\/www.mnb.hu\/en\/arfolyam-lekerdezes"},{"issue":"7","key":"4078_CR27","doi-asserted-by":"publisher","first-page":"e69637","DOI":"10.1371\/journal.pone.0069637","volume":"8","author":"AJ Ferrari","year":"2013","unstructured":"Ferrari AJ, Charlson FJ, Norman RE, Flaxman AD, Patten SB, Vos T, et al. The epidemiological Modelling of major depressive disorder: application for the global burden of disease study 2010. PLoS One. 2013;8(7):e69637.","journal-title":"PLoS One"},{"issue":"1","key":"4078_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12991-019-0248-0","volume":"18","author":"G Li","year":"2019","unstructured":"Li G, Fife D, Wang G, Sheehan JJ, Bod\u00e9n R, Brandt L, et al. All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population. Ann General Psychiatry. 2019;18(1):23.","journal-title":"Ann General Psychiatry"},{"issue":"1","key":"4078_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jad.2013.05.062","volume":"151","author":"R Richieri","year":"2013","unstructured":"Richieri R, Guedj E, Michel P, Loundou A, Auquier P, Lan\u00e7on C, et al. Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis. J Affect Disord. 2013 Oct;151(1):129\u201335.","journal-title":"J Affect Disord"},{"issue":"6","key":"4078_CR30","first-page":"476","volume":"9","author":"FA Kozel","year":"2004","unstructured":"Kozel FA, George MS, Simpson KN. Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression. CNS Spectr. 2004;9(6):476\u201382.","journal-title":"CNS Spectr"},{"key":"4078_CR31","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2147\/PPA.S105654","volume":"10","author":"P Dannon","year":"2016","unstructured":"Dannon P, Magnezi R, Aminov E, Shmuel D, Dreifuss M. Comparison between neurostimulation techniques rapid transcranial magnetic stimulation vs electroconvulsive therapy for the treatment of resistant depression: patient preference and cost-effectiveness. Patient Preference Adherence. 2016;10:1481\u20137.","journal-title":"Patient Preference Adherence"},{"issue":"4","key":"4078_CR32","first-page":"376","volume":"21","author":"YJ Zhao","year":"2018","unstructured":"Zhao YJ, Tor PC, Khoo AL, Teng M, Lim BP, Mok YM. Cost-effectiveness modeling of repetitive Transcranial magnetic stimulation compared to electroconvulsive therapy for treatment-resistant depression in Singapore. Neuromodulation: Technology at the Neural. Interface. 2018;21(4):376\u201382.","journal-title":"Interface."},{"issue":"6","key":"4078_CR33","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1111\/eip.13091","volume":"15","author":"M Teng","year":"2021","unstructured":"Teng M, Khoo AL, Zhao YJ, Abdin E, Mok YM, Lim BP, et al. Neurostimulation therapies in major depressive disorder: a decision-analytic model. Early Interv Psychiatry. 2021;15(6):1531\u201341.","journal-title":"Early Interv Psychiatry"},{"issue":"6","key":"4078_CR34","first-page":"1","volume":"16","author":"Health Quality Ontario","year":"2016","unstructured":"Health Quality Ontario. Repetitive Transcranial magnetic stimulation for treatment-resistant depression: an economic analysis. Ont Health Technol Assess Ser. 2016;16(6):1\u201351.","journal-title":"Ont Health Technol Assess Ser"},{"key":"4078_CR35","first-page":"330","volume":"30","author":"H Ghiasvand","year":"2016","unstructured":"Ghiasvand H, Moradi-Joo M, Abolhassani N, Ravaghi H, Raygani SM, Mohabbat-Bahar S. Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive Transcranial magnetic stimulation with electroconvulsive. Med J Islam Repub Iran. 2016;30:330.","journal-title":"Med J Islam Repub Iran"},{"issue":"7","key":"4078_CR36","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1017\/S0033291714002554","volume":"45","author":"L Vallejo-Torres","year":"2015","unstructured":"Vallejo-Torres L, Castilla I, Gonz\u00e1lez N, Hunter R, Serrano-P\u00e9rez P, Perestelo-P\u00e9rez L. Cost-effectiveness of electroconvulsive therapy compared to repetitive transcranial magnetic stimulation for treatment-resistant severe depression: a decision model. Psychol Med. 2015;45(7):1459\u201370.","journal-title":"Psychol Med"},{"key":"4078_CR37","doi-asserted-by":"publisher","first-page":"070674371989016","DOI":"10.1177\/0706743719890167","volume":"5","author":"KP Fitzgibbon","year":"2019","unstructured":"Fitzgibbon KP, Plett D, Chan BCF, Hancock-Howard R, Coyte PC, Blumberger DM. Cost\u2013utility analysis of electroconvulsive therapy and repetitive transcranial magnetic stimulation for treatment-resistant depression in Ontario. Can J Psychiatry. 2019;5:070674371989016.","journal-title":"Can J Psychiatry"},{"key":"4078_CR38","doi-asserted-by":"crossref","unstructured":"Voigt J, Carpenter L, Leuchter A. Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients \u2013 a lifetime analysis. PLoS One. 2017;12(10):e0186950.","DOI":"10.1371\/journal.pone.0186950"},{"issue":"4","key":"4078_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1017\/S0266462319000576","volume":"35","author":"X Xie","year":"2019","unstructured":"Xie X, Falk L, Brophy JM, Tu HA, Guo J, Gajic-Veljanoski O, et al. A non-inferiority framework for cost-effectiveness analysis. Int J Technol Assess Health Care. 2019;35(4):291\u20137.","journal-title":"Int J Technol Assess Health Care"},{"key":"4078_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpsychires.2019.04.020","volume":"114","author":"I Filip\u010di\u0107","year":"2019","unstructured":"Filip\u010di\u0107 I, \u0160imunovi\u0107 Filip\u010di\u0107 I, Milovac \u017d, Su\u010di\u0107 S, Gaj\u0161ak T, Ivezi\u0107 E, et al. Efficacy of repetitive transcranial magnetic stimulation using a figure-8-coil or an H1-coil in treatment of major depressive disorder; a randomized clinical trial. J Psychiatr Res. 2019;114:113\u20139.","journal-title":"J Psychiatr Res"},{"key":"4078_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cpr.2015.02.003","volume":"41","author":"CL Bockting","year":"2015","unstructured":"Bockting CL, Hollon SD, Jarrett RB, Kuyken W, Dobson K. A lifetime approach to major depressive disorder: the contributions of psychological interventions in preventing relapse and recurrence. Clin Psychol Rev. 2015;41:16\u201326.","journal-title":"Clin Psychol Rev"},{"issue":"9","key":"4078_CR42","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/archpsyc.1991.01810330075011","volume":"48","author":"E Frank","year":"1991","unstructured":"Frank E. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch Gen Psychiatry. 1991;48(9):851.","journal-title":"Arch Gen Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-022-04078-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T01:04:05Z","timestamp":1656378245000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-022-04078-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4078"],"URL":"https:\/\/doi.org\/10.1186\/s12888-022-04078-9","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"8 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not include any patient-level data. The health economic model was populated with data from the literature and simulation. Therefore, this study did not require ethical approval or consent for participation. All methods were performed in accordance with the national guidelines for conducting economic evaluations, as outlined here:\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"437"}}